The other study revealed that blockade of PD-1 worsened progressive renal histopathological and functional injury in murine adriamycin nephropathy, which suggested a possible protective role for PD-1 in chronic renal disease, and its potential as a treatment to slow the disease progression (Qin et al. 2006). This evidence concerns the gene PDCD1 and chronic kidney disease.